Random header image... Refresh for more!

Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System

by admin

Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System

“XIENCE V showed statistically significant superiority to the TAXUS® paclitaxel-eluting coronary stent system”.
Related post here

Bookmark and Share

Related posts:

  1. J&J – Conor CoStar(r) Clinical Trial Stent Stopped
  2. Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions
  3. NEJM — Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
  4. FDA Statement on Coronary Drug-Eluting Stents
  5. J&J Cypher Stent Sort Out III Study VS Medtronic Endeavor Stent

2 comments

1 sayed shafiul alam { 03.25.07 at 1:07 pm }

Looking cardiac interventional product for distributorship in bangladesh.

2 sayed shafiul alam { 03.25.07 at 1:12 pm }

I want to know what is your companys terms& condition for distributor in bangladesh.

Leave a Comment